Sichenzia Ross Ference LLP Represents Sharps Technology, Inc. in $3.8 Million Private Placement Priced At-the-Market
Press Release – New York, NY – February 6, 2023 – Sichenzia Ross Ference LLP announced today that it represented Sharps Technology, Inc. (Nasdaq: STSS and STSSW) (the “Company”), an innovative medical device company offering patented, best-in-class, single use smart safety syringe products, in its private placement priced at-the market. The Company issued 2,248,521 units at a purchase price of $1.69 per unit priced at-the-market under NASDAQ rules. Each unit consists of one share of common stock and one non-tradable warrant exercisable for one share of common stock at a price of $1.56. The warrants have a term of five years from the issuance date. The gross proceeds were $3.8 million before deducting fees to the placement agent and other offering expenses payable by the Company.
The Sichenzia Ross Ference LLP team was led by partner Arthur Marcus and associates Matthew Siracusa, Rohini Sud, and Jack Fattal.